The proportion of new schizophrenia cases linked to cannabis use has nearly tripled in almost two decades, increasing ...
Two new Canadian studies are the largest to date looking at death rates and psychosis associated with cannabis use disorder.
The proportion of new cases of schizophrenia associated with a cannabis use disorder has risen from 4% pre-legalization to 10 ...
A new Canadian study shows a tripling of schizophrenia cases linked to cannabis use disorder since the country legalized it.
New schizophrenia cases linked to cannabis use disorder more than doubled in Ontario after legalisation of drug ...
A study in Ontario found that schizophrenia cases linked to cannabis use disorder have more than doubled since cannabis ...
Jan. 28, 2025 — Schizophrenia is a serious mental disorder that affects around 1% of the world's population. Researchers have identified a deficit in contrast perception in people with ...
Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as ...
The proportion of new cases of schizophrenia associated with a cannabis use disorder has risen from 4% pre-legalization to 10 ...
Neurocrine Biosciences, Inc. ( NASDAQ: NBIX) Q4 2024 Earnings Conference Call February 6, 2025 4:30 PM ET Todd Tushla - Vice President of Investor Relations Kyle Gano - Chief Executive Officer Matt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback